Similar to breast cancer [20] and hepatocellular carcinoma [19], patients with higher SHCBP1 expression had shorter overall survival time than those with lower SHCBP1 expression, indicating that SHCBP1 seems represent an independent prognostic factor for SS patients. Here, SHCBP1 is linked to synovial sarcoma.